A core aspect of the drug development landscape has been and always will be an intimate expertise in therapeutic areas. Our experts will partner with you to design protocols that not only ease the burden of participation, but use the latest advancements in scientific knowledge, data capture, and study design to help you achieve success.
Therapeutic Expertise
A core aspect of the drug development landscape has been and always will be an intimate expertise in therapeutic areas. Our experts will partner with you to design protocols that not only ease the burden of participation, but use the latest advancements in scientific knowledge, data capture, and study design to help you achieve success.
Biosimilars Neuroscience & Pain Oncology Respiratory Cardio-Metabolic Infectious Diseases Immunology Pediatrics Hepatology and NASHExplore related content and topics
White Paper
The Value Of Biobetters
The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biologics are expected to account for approximately 17% of total…
Newsletter
PRA Insights Report 2017
The theme for this year’s DIA 2017 Annual Meeting was “Driving Insights to Action.” DIA hosted more than 7,000 professionals in the pharmaceutical,…
Fact Sheet
Biosimilars Fact Sheet
Biosimilar drug development is unique and complex. At PRA, our cross-functional team of experts guide you through the many nuances of the biosimilar…